Nocodazole - Microtubule Inhibitor / CRISPR Editing Enhancer. CAS# 31430-18-9 60239 suppresses lung cancer cell proliferation

suppresses lung cancer cell proliferation and inhibits tumor growth in vivo

also has less inhibition on AChE/BChE with Ki of 48

selective and cell permeable PARP-3 inhibitor with IC50 of 0

As the hedgehog signaling pathway plays very important roles in embryogenesis and cancer progression

Nocodazole - Microtubule Inhibitor / CRISPR Editing Enhancer. CAS# 31430-18-9 60239 suppresses lung cancer cell proliferationNocodazole, CAS No. 31430 18 9, is a potent microtubule inhibitor to inhibit mitosis. It disrupts microtubules by binding to tubulin and preventing formation of one of the two interchain disulfide linkages, thus inhibiting microtubule dynamics, disruption of mitotic spindle function, and fragmentation of the Golgi complex. Nocodazole arrests the cell cycle at G2 M phase and also prevents phosphorylation of the T cell antigen receptor and inhibits its